HAYWARD, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that Stephen J. Fanning, Chairman, President and Chief Executive Officer of Solta, will be participating in two upcoming investor conferences.
Conference: | Collins Stewart Health Care Event | |
Date: | Wednesday, August 11 | |
Location: | New York City, NY | |
Conference: | 30th Annual Canaccord Genuity Growth Conference | |
Date: | Thursday, August 12 | |
Time: | 10:00 am ET | |
Location: | Boston, MA. | |
Attendance at these conferences is by invitation only.
A live audio webcast of the Company’s presentation at the Canaccord Genuity conference may be accessed at the Investor Relations section of the Company’s website at www.solta.com. An archived replay will be available for 30 days following each event at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry’s three premier brands: Thermage(R), Fraxel(R) and Isolaz(R). Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.
SOURCE Solta Medical, Inc.
